As our network of nurses continues to grow, we are facilitating more decentralised trials and carrying out an ever-increasing number of clinical trial visits to patients in their own homes.

Passionate about putting the patient at the heart of everything we do, LaQuinta shares what she has learnt through the challenges of the pandemic, what she thinks sets us apart from our competitors, and what exciting developments we can expect to see for the company in 2021.

Our Chief Operating Officer, Christopher Kennedy, recently presented at Pharma and Patient USA, a virtual event bringing together leaders in patient-centricity. Christopher shared our perspective on what it takes to deliver remarkable patient experiences to clinical trial participants.

The 21st Century Cures Act was nothing short of revolutionary. Signed into U.S. law on December 13th 2016, it is designed to support the acceleration of medical product development and bring new innovations and advances to patients who need them (FDA.com).

Leah Iles is a homegrown mdgroup talent. Coming from a Commercial Pharma and Med Ed background, she joined the team over 5 years ago as an Account Director and has gone from strength to strength.

Here, we outline the biggest barriers to awareness of clinical research, the roles healthcare practitioners and clinical trial advocates can play in the education of prospective patients, and the most effective ways of improving clinical trial awareness amongst the general public.